bmt: BMT data from Klein and Moeschberger
In mstate: Data Preparation, Estimation and Prediction in Multi-State Models

bmt	R Documentation

BMT data from Klein and Moeschberger

A data frame of 137 rows (patients) and 22 columns. The included variables are

group: Disease group; 1 = ALL, 2 = AML Low Risk, 3 = AML High Risk
t1: Time in days to death or last follow-up
t2: Disease-free survival time in days (time to relapse, death or last follow-up)
d1: Death indicator; 1 = dead, 0 = alive
d2: Relapse indicator; 1 = relapsed, 0 = disease-free
d3: Disease-free survival indicator; 1 = dead or relapsed, 0 = alive and disease-free)
ta: Time in days to Acute Graft-versus-Host Disease (AGVHD)
da: Acute GVHD indicator; 1 = Acute GVHD, 0 = No Acute GVHD
tc: Time (days) to Chronic Graft-vrsus-Host Disease (CGVHD)
dc: Chronic GVHD indicator; 1 = Chronic GVHD, 0 = No Chronic GVHD
tp: Time (days) to platelet recovery
dp: Platelet recovery indicator; 1 = platelets returned to normal, 0 = platelets never returned to normal
z1: Patient age in years
z2: Donor age in years
z3: Patient sex; 1 = male, 0 = female
z4: Donor sex; 1 = male, 0 = female
z5: Patient CMV status; 1 = CMV positive, 0 = CMV negative
z6: Donor CMV status; 1 = CMV positive, 0 = CMV negative
z7: Waiting time to transplant in days
z8: FAB; 1 = FAB grade 4 or 5 and AML, 0 = Otherwise
z9: Hospital; 1 = The Ohio State University, 2 = Alferd , 3 = St. Vincent, 4 = Hahnemann
z10: MTX used as a Graft-versus-Host prophylactic; 1 = yes, 0 = no